ImetelChat

says PDUFA June 16th and review completion by end of 2024?

https://www.youtube.com/watch?v=owIlqs_a-6A

around 47 minute mark and listen to the questions at the end - think there is a lot of interest in imetelstat due to treating high transfusion burden and also the ability to modify the disease

a very good listen - a nice long discussion on imetelstat - still surprised did not get priority review

Unable to read due to paywall

This is what I have been saying - disease modification is the key - I would want to fight the disease and not cover it up

between 4:40 and 5:30 more than 3.3 million shares were bought - that is a lot of after hours buying

Someone on Twitter from the investing side of the world said the ADCOM was in April - and he posted this a few weeks after the announcement of standard review was made public - I think I posted that here The FDA had boots on the ground at the EHA - wonder if they could have spoken with thr KOL’s and...

on the video posted by BP - you can go to the 9:30 minute mark

https://www.vjhemonc.com/feature/spotli ... -risk-mds/

Did you see these - can see positivity especially is UWE and Valeria on the videos near the bottom - I posted this couple days ago

Didn’t he promise shareholder value this year - we neeed a stock price increase

https://x.com/madanatyazan/status/1734606123238621596?s=46&t=8uzUHw9EtNsCCXgoldHN1Q Really worth your time to go on Twitter and search imetelstat - no way it isn’t being approved and it will be first line for heavily transfused And yes, I agree. The 5 g is really the huge number even if they’re stil...

The big names is MDS seem to be excited about Imetelstat - a lot of positive buzz at meeting

https://x.com/MikkaelSekeres/status/173 ... 49387?s=20

would the FDA ever consult a group like this?